NovaGene TherapeuticsNext move: Send Dana the scheduled follow-up
Last contacted
Jul 3, 2026 • 1:49 PM
19 days ago
You are here
Today
Jul 22, 2026
Next step
Jul 27, 2026
in 5 days
Once NovaGene Therapeutics is classified, the services relevant to Dana's role will appear here.
Classify NovaGene Therapeutics and every offering that fits Dana's role shows up here — ready to pitch.
Classify NovaGene Therapeutics nowBuilt RA from scratch; needs scalable submission capacity.
VP Regulatory Affairs
NovaGene Therapeutics · Present
The other people you know at NovaGene Therapeutics. Deals stall when they hang on one person — the more contacts you're talking to, the safer it is. Click anyone to open them.
Dana is your only contact at NovaGene Therapeutics right now — that's risky. Find a second person (a peer or their manager) so the deal doesn't rest on one relationship.
Your next best move
Send Dana the scheduled follow-up
A follow-up is due — draft the recap with a concrete next step.
Inferred buying style: Conscientious — detail-driven & risk-averse
Evidence-led and precise. Trusts specifics, frameworks, and a clean track record.
Dana — VP Regulatory Affairs at NovaGene Therapeutics. A follow-up is due Jul 27, 2026. Recommended next move: Send Dana the scheduled follow-up.
Recommended: Send Dana the scheduled follow-up
Wants IND-to-BLA roadmap.